We have observed
16 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 13, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANALYSING VITAMIN D METABOLITES IN DRIED BLOOD
ASSAY METHOD FOR INTRINSIC ACUTE KIDNEY INJURY
PROCESS FOR PREPARING HUMAN RELAXIN-2
Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients
Articulating drill guide
HEAT-EXPANDABLE MICROSPHERES, PROCESS FOR PRODUCING SAME, AND USES
RELAXIN FOR TREATING PATIENTS AFFLICTED OF IMPAIRED GLUCOSE TOLERANCE
MEANS AND METHODS OF MEASURING PARATHYROID HORMONE IN PATIENTS SUFFERING FROM OXIDATIVE STRESS
Quantitative analysis of contact-depending cell-to-cell transfer and disease transmission
Method and composition for treating heart failure with preserved ejection fraction
IN VITRO DIAGNOSTIC AND PROGNOSIS OF CONTRAST INDUCED NEPHROPATHY (CIN) IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
METHOD AND KIT OF PARTS FOR EXTRACTION OF NUCLEIC ACIDS
METHOD AND COMPOSITION FOR TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION
METHOD OF EXTRACTING NUCLEIC ACIDS
BONE SIALOPROTEIN(BSP)-FUNCTIONALISED BONE REPLACEMENT BODIES
APPARATUS AND METHOD FOR CONVERTING ELECTROMAGNETIC RADIATION INTO THERMAL ENERGY